论文部分内容阅读
自从1891年Luecke首次施行肝肿瘤切除术成功以来,随着外科操作的提高,麻醉方法的改进,肝功能和解剖的了解和掌握,广谱抗菌素的发明以及抗休克和保肝治疗的应用,使肝叶切除患者的危险性不断减少,疗效日渐提高。目前肝叶切除术已普遍应用于原发性肝癌(以下简称肝癌)的治疗。但迄今肝叶切除治疗肝癌的疗效仍然不够理想。其原因很多,如诊断问题、肝硬变基础、定位诊断,生长部位以及巨体类型等各种因素的影响,使肝叶切除术的疗效受到很大的限制。如果不考虑这些方面,就产生对肝叶切除治疗肝癌的估价不够确切。1972年开展普查以来,肝癌病例的早期发现增多。通过早期诊断能否提高肝叶切除术的切除率和疗效?本文根据我院1972～1978年治疗早期(即Ⅰ期)、中期肝癌(即Ⅱ期)42例其中手
Since Luecke’s first successful liver tumor resection in 1891, with the improvement of surgical operations, improvement of anesthetic methods, understanding and mastering of liver function and anatomy, development of broad-spectrum antibiotics, and application of anti-shock and hepatoprotective treatments, The risk of patients with hepatic lobectomy is continuously decreasing, and the curative effect is gradually increasing. Currently liver lobectomy has been widely used in the treatment of primary liver cancer (hereinafter referred to as liver cancer). However, the effect of liver lobectomy for liver cancer has so far been unsatisfactory. There are many reasons for this, such as the diagnosis, cirrhosis, positioning diagnosis, growth site, and the type of the giant body, which greatly limits the efficacy of hepatectomy. If these aspects are not taken into account, the assessment of liver lobectomy for liver cancer is not yet accurate. Since the census began in 1972, early detection of liver cancer cases has increased. Through early diagnosis can improve the resection rate and efficacy of liver lobectomy? This article based on our hospital from 1972 to 1978 treatment of early (ie, phase I), metaphase liver cancer (ie, phase II) of 42 cases in which the hand